Crossmark

Emphasizing the use of semaglutide; a significant advancement in the management of chronic kidney disease in diabetic patients

Published Online: 2024-08-19

Authors

Fasieh, Haleema

Naeem, Amna Binte

Hussain, Mubashir
License Information

Text and Data Mining valid from 2024-08-19

Version of Record valid from 2024-08-19
More Information

Article History

Received: 11 August 2024

Accepted: 13 August 2024

First Online: 19 August 2024

Declarations

:

: The authors declare no competing interests.

Document is current